Belite Bio, Inc (BLTE)

NASDAQ: BLTE · Real-Time Price · USD

175.84

+0.58 (0.33%)

At close: Feb 17, 2026, 4:00 PM EST

174.80

-1.04 (-0.59%)

After-hours: Feb 17, 2026, 5:20 PM EST

Belite Bio Employees

Belite Bio had 25 employees as of December 31, 2024. The number of employees increased by 5 or 25.00% compared to the previous year.

Employees

25

Change (1Y)

5

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$2,495,480

Market Cap

6.60B

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	25	5	25.00%
Dec 31, 2023	20	4	25.00%
Dec 31, 2022	16	4	33.33%
Dec 31, 2021	12	-	-

Related Stocks

Company Name	Employees
Caris Life Sciences	1,769
PTC Therapeutics	939
ImmunityBio	673
Cytokinetics	498
Vaxcyte	414
Mirum Pharmaceuticals	355
Rhythm Pharmaceuticals	283
Krystal Biotech	275

Employee Rankings

BLTE News

2 months ago - Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares - GlobeNewsWire
2 months ago - Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares - GlobeNewsWire
2 months ago - Belite Bio, Inc (BLTE) Discusses Positive Topline Results from Phase III DRAGON Trial of Tinlarebant in Stargardt Disease Transcript - Seeking Alpha
2 months ago - Belite Bio Scores First Successful Phase 3 Trial For Rare Vision-Loss Disease - Benzinga
2 months ago - Belite Bio's drug for genetic eye disease meets main goal in late-stage trial - Reuters
2 months ago - New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease - GlobeNewsWire
3 months ago - Belite Bio, Inc (BLTE) Q3 2025 Earnings Call Transcript - Seeking Alpha
3 months ago - Belite Bio, Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference 2025 Prepared Remarks Transcript - Seeking Alpha